Key facts
- Elvie’s last known valuation is $241.0M (Dec 2022).
- It has raised $186.6M; the latest was Merger/Acquisition in Mar 2025.
- Status: Acquired/Merged (Operating Subsidiary).
- ·Watchlist + deal alerts for Elvie
- ·The full record, as it builds
Funding rounds
No funding rounds for Elvie are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Elvie
Developer of feminocentric products designed to improve women's lives through smarter technology. The company's platform includes an application-connected Kegal trainer to strengthen the pelvic floor using five-minute workouts with real-time biofeedback and a silent wearable breast pump, enabling women to improve their health after pregnancy.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2013
- Employees
- 200
- Website
- elvie.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Elvie doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Elvie shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Elvie in its N-PORT filings yet. We sweep new filings monthly.